NEW YORK, March 3 (GenomeWeb News) - Shares in Harvard Bioscience were down 5.73 percent,or $.30, at $4.94 in afternoon trade after the company late yesterday reported marginal fourth-quarter revenue gains and a $8.9-million loss.
As GenomeWeb News reported this morning, the company posted a 2.4-percent increase in revenues to $7.8 million.